Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1194881018 | Co-flumactone (product) | en | Fully specified name | Inactive | Case sensitive | SNOMED CT core |
| 2572079017 | Hydroflumethiazide + spironolactone (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 2576053011 | Hydroflumethiazide + spironolactone | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3485074019 | Product containing hydroflumethiazide and spironolactone (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3493571017 | Product containing hydroflumethiazide and spironolactone | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3666640014 | Hydroflumethiazide and spironolactone product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3715206010 | Hydroflumethiazide- and spironolactone-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 472857010 | Co-flumactone | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 727203010 | Co-flumactone (substance) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hydroflumethiazide- and spironolactone-containing product | Plays role | Potassium-sparing diuretic therapeutic role | true | Inferred relationship | Some | ||
| Hydroflumethiazide- and spironolactone-containing product | Is a | Spironolactone+thiazide diuretic | false | Inferred relationship | Some | ||
| Hydroflumethiazide- and spironolactone-containing product | Has active ingredient | Diuretic | false | Inferred relationship | Some | ||
| Hydroflumethiazide- and spironolactone-containing product | Has active ingredient | Hydroflumethiazide | true | Inferred relationship | Some | 2 | |
| Hydroflumethiazide- and spironolactone-containing product | Has active ingredient | Spironolactone | true | Inferred relationship | Some | 1 | |
| Hydroflumethiazide- and spironolactone-containing product | Is a | Hydroflumethiazide-containing product | true | Inferred relationship | Some | ||
| Hydroflumethiazide- and spironolactone-containing product | Is a | Spironolactone-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hydroflumethiazide and spironolactone only product | Is a | True | Hydroflumethiazide- and spironolactone-containing product | Inferred relationship | Some | |
| Hydroflumethiazide 25 mg and spironolactone 25 mg oral tablet | Is a | False | Hydroflumethiazide- and spironolactone-containing product | Inferred relationship | Some | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Is a | False | Hydroflumethiazide- and spironolactone-containing product | Inferred relationship | Some | |
| Hydroflumethiazide- and spironolactone-containing product in oral dose form | Is a | True | Hydroflumethiazide- and spironolactone-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR